THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Anjan Pradhan to Female

This is a "connection" page, showing publications Anjan Pradhan has written about Female.
Connection Strength

0.171
  1. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
    View in: PubMed
    Score: 0.060
  2. mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Res. 2017 02 15; 77(4):949-959.
    View in: PubMed
    Score: 0.044
  3. A novel computational predictive biological approach distinguishes Integrin ?1 as a salient biomarker for breast cancer chemoresistance. Biochim Biophys Acta Mol Basis Dis. 2023 08; 1869(6):166702.
    View in: PubMed
    Score: 0.017
  4. Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo. Oncogene. 2018 08; 37(33):4546-4561.
    View in: PubMed
    Score: 0.012
  5. Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Lett. 2017 03 01; 388:292-302.
    View in: PubMed
    Score: 0.011
  6. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Oncotarget. 2016 Aug 23; 7(34):54102-54119.
    View in: PubMed
    Score: 0.011
  7. Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther. 2014 Feb 10; 16(1):R49.
    View in: PubMed
    Score: 0.009
  8. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide. Biochim Biophys Acta. 2013 Oct; 1833(10):2357-68.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES